Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury

NCT02917291 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Traumatic Spinal Cord Injury

Interventions

DRUG: FAB117-HC
OTHER: Control group
DRUG: FAB117-HC

Sponsor

Ferrer Internacional S.A.

Collaborators

[object Object]